Judge Sets Deadline for Post-Trial Briefs In Zyprexa Case

Law360, New York (March 3, 2004, 12:00 AM EST) -- A federal judge has given both sides in the patent trial over Eli Lilly's Zyprexa schizophrenia drug until May 12 to file all of their post-trial briefs.

U.S. District Court Judge Richard L. Young last week also extended a stay barring the sale of generic Zyprexa until a verdict is handed down.

Young set the post-trial deadlines last week, after Lilly and the two main defendants couldn't agree to a schedule on their own.

Young ordered defendants Zenith Goldline Pharmaceuticals and Dr. Reddy's Laboratories to file...
To view the full article, register now.